2,5-Dimethoxy-4-ethylamphetamine

From WikiMD's WELLNESSPEDIA

What is 2,5-Dimethoxy-4-ethylamphetamine?[edit]

2,5-Dimethoxy-4-ethylamphetamine
  • It is a psychedelic drug of the phenethylamine and amphetamine chemical classes.
  • It acts as a 5-HT2A, 5-HT2B, and 5-HT2C receptor partial agonist.
  • IUPAC Name: 1-(4-ethyl-2,5-dimethoxyphenyl)propan-2-amine
  • InChI: InChI=1S/C13H21NO2/c1-5-10-7-13(16-4)11(6-9(2)14)8-12(10)15-3/h7-9H,5-6,14H2,1-4H3
  • InChI Key: HXJKWPGVENNMCC-UHFFFAOYSA-N
  • Canonical SMILES: CCC1=CC(=C(C=C1OC)CC(C)N)OC
  • Molecular formula: C13H21NO2
  • Molecular weight: 223.31 g·mol−1
  • PubChem CID: 27402
  • Synonyms:
  1. 22004-32-6
  2. 1-(4-ethyl-2,5-dimethoxyphenyl)propan-2-amine
  3. 4-Ethyl-2,5-dimethoxyamphetamine
  4. CHEMBL8224
  5. Benzeneethanamine, 4-ethyl-2,5-dimethoxy-alpha-methyl-
  6. DEA No. 7399
  7. NCGC00247691-01
  8. DOET,(-)
  9. SCHEMBL1740704
  10. BDBM81965
  11. DTXSID00860585
  12. CAS_62066
  13. NSC_62066
  14. PDSP1_000797
  15. PDSP1_001371
  16. PDSP2_000785
  17. PDSP2_001355
  18. DB01467
  19. 2,5-dimethoxy-4-ethylamphetamine (DOEt)
  20. L001150
  21. Q947249
  22. 1-(4-Ethyl-2,5-dimethoxyphenyl)-2-propanamine #
  23. Phenethylamine, 4-ethyl-2,5-dimethoxy-alpha-methyl-

[1]

References[edit]

  1. National Center for Biotechnology Information (2021). PubChem Compound Summary for CID 27402, 2,5-Dimethoxy-4-ethylamphetamine. Retrieved August 11, 2021 from [1].






This article is a stub related to pharmacology. You can help WikiMD by expanding it!

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.